| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a compound representing 4-methylbenzene sulphonate 6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulphonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide, and to its new crystalline form. The invention also refers to a method for preparing the above compound and to a pharmaceutical composition, for treating a disease or a condition wherein inhibition of neutrophilic elastase activity with the above compound and/or crystalline form is considered to be effective. n EFFECT: what is prepared is the new compound and its crystalline form which can find application in medicine for treating an inflammatory disease or condition, such as COPD (chronic obstructive pulmonary disease). n 15 cl, 8 dwg, 10 tbl, 16 ex |